Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and...
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
About this item
Full title
Author / Creator
Catenacci, Daniel V. T. , Liao, Wei-Li , Zhao, Lei , Whitcomb, Emma , Henderson, Les , O’Day, Emily , Xu, Peng , Thyparambil, Sheeno , Krizman, David , Bengali, Kathleen , Uzzell, Jamar , Darfler, Marlene , Cecchi, Fabiola , Blackler, Adele , Bang, Yung-Jue , Hart, John , Xiao, Shu-Yuan , Lee, Sang Mee , Burrows, Jon and Hembrough, Todd
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Background
Trastuzumab has shown a survival benefit in cases of Her2-positive gastroesophageal cancer (GEC). Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) currently determine eligibility for trastuzumab-based therapy. However, these low-throughput assays often produce discordant or equivocal results.
Methods
We d...
Alternative Titles
Full title
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4871781
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4871781
Other Identifiers
ISSN
1436-3291
E-ISSN
1436-3305
DOI
10.1007/s10120-015-0566-0
